From: Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
Parameter/agent
Caspofungin
Micafungin
Anidulafungin
cost-effectiveness in invasive candidiasis/candidemia
X
cost-effectiveness in suspected infections
Lowering the incidence of IRF
cost-effectiveness in prophylaxis